Latest Distributions News

Oceania Healthcare Limited reported a robust FY25 with a 9.2% rise in sales volume and a 5.8% increase in comprehensive income, underpinned by a successful $500 million debt refinancing and operational enhancements.

EBR Systems has raised A$55.9 million through a fully underwritten placement to fund the commercial rollout of its FDA-approved wireless cardiac pacing system, with plans for a limited market release in H2 2025 and expanded distribution in 2026.

MA Financial Group is set to acquire Melbourne-based IP Generation, adding $2 billion in assets and boosting its real estate management platform to over $12 billion AUM. The deal is expected to enhance earnings in FY25 and deepen MA’s presence in the retail real estate sector.

Far Northern Resources has reported promising Phase 1 drilling results at its Bridge Creek gold project, revealing significant gold grades and extending mineralisation footprints both north and south of the current resource. The company awaits further assay results to refine future drilling plans.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Lincoln Minerals’ Kookaburra Graphite Project has delivered battery-grade graphite purity exceeding 99.95%, confirming its suitability for lithium-ion battery anodes through a safer, hydrofluoric acid-free process.

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

Dicker Data reported a 2.9% increase in FY24 gross revenue to $3.37 billion with stable EBITDA, while FY25 starts strong with 17.4% sales growth driven by AI and Windows 10 refresh demand.

Bell Financial Group delivered strong financial results for 2024, driven by growth in technology and product services, but early 2025 shows challenges from market volatility impacting core broking revenues.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.